These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 25884215

  • 1. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN, Caliari-Oliveira C, de Souza LE, Neto LS, Palma PV, Covas DT, Malmegrim KC, Voltarelli JC, Donadi EA.
    Stem Cell Res Ther; 2015 Mar 14; 6(1):31. PubMed ID: 25884215
    [Abstract] [Full Text] [Related]

  • 2. Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice.
    Sun LL, Liu TJ, Li L, Tang W, Zou JJ, Chen XF, Zheng JY, Jiang BG, Shi YQ.
    Int J Mol Med; 2017 Apr 14; 39(4):936-948. PubMed ID: 28290605
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN, de Lima KW, Caliari-Oliveira C, Palma PV, Couri CE, Simões BP, Covas DT, Voltarelli JC, Oliveira MC, Donadi EA, Malmegrim KC.
    Stem Cell Res Ther; 2016 Jan 18; 7():14. PubMed ID: 26781648
    [Abstract] [Full Text] [Related]

  • 5. Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice.
    Hashemi SM, Hassan ZM, Hossein-Khannazer N, Pourfathollah AA, Soudi S.
    Inflammopharmacology; 2020 Apr 18; 28(2):585-601. PubMed ID: 31741175
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model.
    Daneshmandi S, Karimi MH, Pourfathollah AA.
    Int Immunopharmacol; 2017 Mar 18; 44():191-196. PubMed ID: 28110219
    [Abstract] [Full Text] [Related]

  • 9. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice.
    Ho JH, Tseng TC, Ma WH, Ong WK, Chen YF, Chen MH, Lin MW, Hong CY, Lee OK.
    Cell Transplant; 2012 Mar 18; 21(5):997-1009. PubMed ID: 22004871
    [Abstract] [Full Text] [Related]

  • 10. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H, Liu J, Shen J, Zhao Y, Liu H, Hou Q, Tong C, Ti D, Dong L, Cheng Y, Mu Y, Liu J, Fu X, Han W.
    Biochem Biophys Res Commun; 2013 Jul 05; 436(3):418-23. PubMed ID: 23770360
    [Abstract] [Full Text] [Related]

  • 11. Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.
    Rahavi H, Hashemi SM, Soleimani M, Mohammadi J, Tajik N.
    J Diabetes Res; 2015 Jul 05; 2015():878535. PubMed ID: 25893202
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
    Mohammadi Ayenehdeh J, Niknam B, Rasouli S, Hashemi SM, Rahavi H, Rezaei N, Soleimani M, Liaeiha A, Niknam MH, Tajik N.
    Immunol Lett; 2017 Aug 05; 188():21-31. PubMed ID: 28506774
    [Abstract] [Full Text] [Related]

  • 15. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
    Dao LT, Park EY, Lim SM, Choi YS, Jung HS, Jun HS.
    Transplantation; 2014 Nov 27; 98(10):1040-7. PubMed ID: 25208321
    [Abstract] [Full Text] [Related]

  • 16. Adipose-derived mesenchymal stem cells ameliorate STZ-induced pancreas damage in type 1 diabetes.
    Li YY, Liu HH, Chen HL, Li YP.
    Biomed Mater Eng; 2012 Nov 27; 22(1-3):97-103. PubMed ID: 22766707
    [Abstract] [Full Text] [Related]

  • 17. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
    Xin Y, Jiang X, Wang Y, Su X, Sun M, Zhang L, Tan Y, Wintergerst KA, Li Y, Li Y.
    PLoS One; 2016 Nov 27; 11(1):e0145838. PubMed ID: 26756576
    [Abstract] [Full Text] [Related]

  • 18. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM, Hegab AS, Al-Shahat A, Raafat N.
    Int J Biochem Cell Biol; 2017 Jun 27; 87():77-85. PubMed ID: 28385600
    [Abstract] [Full Text] [Related]

  • 19. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F, Ezquer M, Contador D, Ricca M, Simon V, Conget P.
    Stem Cells; 2012 Aug 27; 30(8):1664-74. PubMed ID: 22644660
    [Abstract] [Full Text] [Related]

  • 20. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
    Xiao N, Zhao X, Luo P, Guo J, Zhao Q, Lu G, Cheng L.
    Cytotherapy; 2013 Nov 27; 15(11):1374-84. PubMed ID: 24094489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.